Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCH
5226
PUT
Dauch Corp
DCH
$1.35B
| $282K | ﹤0.01% |
18,300
-15,800
| -46% | -$228K |
|
5227
Teladoc Health
TDOC
$1.21B
| $282K | ﹤0.01% |
29,411
-443
| -1% | -$6.29K |
|
5228
ProShares VIX Short-Term Futures ETF
VIXY
$182M
| $282K | ﹤0.01% |
15
+5
| +50% | +$125K |
|
|
MDR
5229
CALL
DELISTED
McDermott International
MDR
| $282K | ﹤0.01% |
22,967
+1,234
| +6% | +$11.7K |
|
|
RBPAA
5230
DELISTED
Royal Bancshares Of Pennsylvania Inc
RBPAA
| $282K | ﹤0.01% |
132,162
+17,741
| +16% | +$35.7K |
|
|
BYLK
5231
DELISTED
BAYLAKE CORP
BYLK
| $282K | ﹤0.01% |
+17,663
| New | +$261K |
|
5232
Crawford & Co Class A
CRD.A
$625M
| $281K | ﹤0.01% |
46,759
+22,832
| +95% | +$109K |
|
5233
BlackRock Floating Rate Income Strategies Fund
FRA
$384M
| $280K | ﹤0.01% |
+21,452
| New | +$269K |
|
|
SRSC
5234
DELISTED
SEARS Canada Inc.
SRSC
| $280K | ﹤0.01% |
100,233
+1,439
| +1% | +$4.75K |
|
5235
PUT
Sprouts Farmers Market
SFM
$8.13B
| $279K | ﹤0.01% |
9,600
-2,400
| -20% | -$61.9K |
|
5236
Brookfield Infrastructure Partners
BIP
$17.9B
| $278K | ﹤0.01% |
16,632
-55,158
| -77% | -$800K |
|
5237
CALL
NetApp
NTAP
$37.6B
| $278K | ﹤0.01% |
10,200
-508,500
| -98% | -$12.3M |
|
5238
Powell Industries
POWL
$7.55B
| $278K | ﹤0.01% |
28,011
-7,461
| -21% | -$65.9K |
|
5239
Vericel Corp
VCEL
$2.29B
| $278K | ﹤0.01% |
47,471
+30,568
| +181% | +$85.7K |
|
|
WPRT
5240
Westport Fuel Systems
WPRT
$35.1M
| $278K | ﹤0.01% |
10,638
+3,663
| +53% | +$77.2K |
|
|
CY
5241
PUT
DELISTED
Cypress Semiconductor
CY
| $278K | ﹤0.01% |
32,100
-7,900
| -20% | -$63.8K |
|
5242
Customers Bancorp
CUBI
$2.77B
| $277K | ﹤0.01% |
11,724
-12,167
| -51% | -$291K |
|
|
ESSA
5243
DELISTED
ESSA Bancorp
ESSA
| $277K | ﹤0.01% |
+20,536
| New | +$276K |
|
5244
Nathan's Famous
NATH
$403M
| $277K | ﹤0.01% |
+6,358
| New | +$309K |
|
5245
PUT
ScottsMiracle-Gro
SMG
$3.61B
| $277K | ﹤0.01% |
3,800
+3,700
| +3,700% | +$252K |
|
|
EGLT
5246
DELISTED
Egalet Corporation
EGLT
| $277K | ﹤0.01% |
40,328
+20,551
| +104% | +$161K |
|
|
UCFC
5247
DELISTED
United Community Financial Corp
UCFC
| $276K | ﹤0.01% |
46,997
+34,549
| +278% | +$200K |
|
|
GUID
5248
DELISTED
Guidance Software, Inc.
GUID
| $276K | ﹤0.01% |
+64,067
| New | +$309K |
|
5249
Minerva Neurosciences
NERV
$207M
| $275K | ﹤0.01% |
5,598
+1,547
| +38% | +$66.1K |
|
5250
Anavex Life Sciences
AVXL
$304M
| $274K | ﹤0.01% |
+55,940
| New | +$246K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.